S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
A One Stop Shop for Everything Futures Trading (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
UK government drops key part of tax cuts package that sparked market turmoil, sent pound plunging
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
A One Stop Shop for Everything Futures Trading (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
UK government drops key part of tax cuts package that sparked market turmoil, sent pound plunging
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
A One Stop Shop for Everything Futures Trading (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
UK government drops key part of tax cuts package that sparked market turmoil, sent pound plunging
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
A One Stop Shop for Everything Futures Trading (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
UK government drops key part of tax cuts package that sparked market turmoil, sent pound plunging
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Voter apathy in Bulgaria opens door for pro-Russia groups
NASDAQ:SIBN

SI-BONE - SIBN Stock Forecast, Price & News

$17.46
+0.21 (+1.22%)
(As of 09/30/2022 09:02 PM ET)
Add
Compare
Today's Range
$17.01
$18.25
50-Day Range
$13.44
$18.71
52-Week Range
$11.89
$25.00
Volume
123,100 shs
Average Volume
252,526 shs
Market Capitalization
$591.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.57

SI-BONE MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
57.9% Upside
$27.57 Price Target
Short Interest
Healthy
5.88% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
0.63mentions of SI-BONE in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$456,222 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.89) to ($1.60) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars

Medical Sector

558th out of 1,095 stocks

Surgical & Medical Instruments Industry

58th out of 106 stocks

SIBN stock logo

About SI-BONE (NASDAQ:SIBN) Stock

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

SIBN Stock News Headlines

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?
Si-Bone Inc (SIBN)
Aurora Spine Has Three Shots On Goal
SI-BONE: Q4 Earnings Insights
See More Headlines
Receive SIBN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter.

SIBN Company Calendar

Last Earnings
8/08/2022
Today
10/03/2022
Next Earnings (Estimated)
11/14/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SIBN
Fax
N/A
Employees
352
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$27.57
High Stock Price Forecast
$36.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+57.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-56,570,000.00
Pretax Margin
-69.37%

Debt

Sales & Book Value

Annual Sales
$90.15 million
Book Value
$4.01 per share

Miscellaneous

Free Float
32,054,000
Market Cap
$591.61 million
Optionable
Not Optionable
Beta
1.24

Key Executives

  • Ms. Laura A. Francis MBAMs. Laura A. Francis MBA (Age 55)
    CEO & Director
    Comp: $879.74k
  • Mr. Anshul Maheshwari (Age 44)
    Chief Financial Officer
    Comp: $511.05k
  • Mr. Anthony J. RecuperoMr. Anthony J. Recupero (Age 63)
    Pres of Commercial Operations
    Comp: $665.91k
  • Mr. Michael A. PisetskyMr. Michael A. Pisetsky (Age 44)
    Sr. VP of Operations & Admin., Sec. and Chief Legal Officer
  • Mr. Jeff Bertolini
    Sr. VP of Operations & Information Technology
  • Dr. Scott A. Yerby (Age 54)
    Sr. VP of Engineering & CTO
  • Mr. Joseph W. Powers (Age 62)
    VP of Corp. Marketing
  • Dr. Daniel Joseph Cher (Age 57)
    Sr. VP of Clinical & Regulatory Affairs
  • Dr. W. Carlton Reckling (Age 60)
    Chief Medical Officer & VP of Medical Affairs
  • Mr. Nikolas F. Kerr (Age 50)
    Sr. VP of Product, Strategy & Bus. Devel.













SIBN Stock - Frequently Asked Questions

Should I buy or sell SI-BONE stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SI-BONE in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SIBN shares.
View SIBN analyst ratings
or view top-rated stocks.

What is SI-BONE's stock price forecast for 2022?

6 brokerages have issued 1 year price objectives for SI-BONE's stock. Their SIBN share price forecasts range from $17.00 to $36.00. On average, they expect the company's share price to reach $27.57 in the next twelve months. This suggests a possible upside of 57.9% from the stock's current price.
View analysts price targets for SIBN
or view top-rated stocks among Wall Street analysts.

How have SIBN shares performed in 2022?

SI-BONE's stock was trading at $22.21 at the start of the year. Since then, SIBN stock has decreased by 21.4% and is now trading at $17.46.
View the best growth stocks for 2022 here
.

When is SI-BONE's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 14th 2022.
View our SIBN earnings forecast
.

How were SI-BONE's earnings last quarter?

SI-BONE, Inc. (NASDAQ:SIBN) posted its earnings results on Monday, August, 8th. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.49) by $0.05. SI-BONE had a negative trailing twelve-month return on equity of 51.84% and a negative net margin of 69.36%. During the same period last year, the firm earned ($0.42) earnings per share.

What guidance has SI-BONE issued on next quarter's earnings?

SI-BONE updated its FY 2022 earnings guidance on Tuesday, September, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $106.00 million-$108.00 million, compared to the consensus revenue estimate of $107.26 million.

What is Jeffrey Dunn's approval rating as SI-BONE's CEO?

10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of SI-BONE own?
When did SI-BONE IPO?

(SIBN) raised $84 million in an initial public offering on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-BONE's stock symbol?

SI-BONE trades on the NASDAQ under the ticker symbol "SIBN."

How do I buy shares of SI-BONE?

Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SI-BONE's stock price today?

One share of SIBN stock can currently be purchased for approximately $17.46.

How much money does SI-BONE make?

SI-BONE (NASDAQ:SIBN) has a market capitalization of $591.54 million and generates $90.15 million in revenue each year. The company earns $-56,570,000.00 in net income (profit) each year or ($1.97) on an earnings per share basis.

How many employees does SI-BONE have?

The company employs 352 workers across the globe.

How can I contact SI-BONE?

SI-BONE's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The official website for the company is www.si-bone.com. The company can be reached via phone at (408) 207-0700 or via email at investors@si-bone.com.

This page (NASDAQ:SIBN) was last updated on 10/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.